Nanjing Zhulu Pharmaceutical Technology

Nanjing Zhulu Pharmaceutical Technology is a China-based biotechnology company specializing in the research, development, and technical services of pharmaceutical intermediates and active pharmaceutical ingredients (APIs). Established in 2017 and headquartered in the Nanjing Jiangbei New Area, the company functions as a Contract Research Organization (CRO) and Contract Development and Manufacturing Organization (CDMO) with a core focus on small molecule chemical synthesis. Their service portfolio includes technology transfer, technical consulting, and the development of high-end generic drugs. The company supports pharmaceutical clients by providing high-quality chemical building blocks and process optimization for drug discovery and development. Nanjing Zhulu is recognized as a technology-driven small and medium-sized enterprise (SME) within the Jiangsu provincial innovation ecosystem.